Suppr超能文献

面肩肱型肌营养不良症的肌电图检查:一项为期 1 年的随访研究。

Electrical impedance myography in facioscapulohumeral muscular dystrophy: A 1-year follow-up study.

机构信息

Department of Neurology, University of Kansas Medical Center, 4330 Shawnee Mission Parkway, Suite 323 Fairway, Kansas, 66205, USA.

Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

出版信息

Muscle Nerve. 2018 Aug;58(2):213-218. doi: 10.1002/mus.26127. Epub 2018 Apr 17.

Abstract

INTRODUCTION

Electrical impedance myography (EIM) is a noninvasive technique for measuring muscle composition and a potential physiological biomarker for facioscapulohumeral muscular dystrophy (FSHD).

METHODS

Thirty-two participants with genetically confirmed and clinically affected FSHD underwent EIM in 7 muscles bilaterally. Correlations between EIM and baseline clinical measures were used to select EIM variables of interest in FSHD, and EIM and clinical measures were followed for 1 year.

RESULTS

There were no significant changes in the EIM variables. Although 50-kHZ reactance correlated the strongest with clinical measures at baseline, the 50-211-kHZ phase ratio demonstrated lower within-subject 12-month variability, potentially offering sample size savings for FSHD clinical trial planning.

DISCUSSION

EIM did not identify significant disease progression over 12 months. It is currently unclear whether this is because of limitations of the technology or the slow rate of disease progression in this cohort of FSHD patients over this period of time. Muscle Nerve 58: 213-218, 2018.

摘要

简介

电阻抗肌描记法(EIM)是一种用于测量肌肉成分的非侵入性技术,也是面肩肱型肌营养不良症(FSHD)的潜在生理生物标志物。

方法

32 名经基因证实且临床表现为 FSHD 的患者接受了双侧 7 块肌肉的 EIM 检查。EIM 与基线临床指标的相关性用于选择 FSHD 中感兴趣的 EIM 变量,并对 EIM 和临床指标进行了 1 年的随访。

结果

EIM 变量无显著变化。虽然 50-kHz 电抗在基线时与临床指标相关性最强,但 50-211-kHz 相位比的个体内 12 个月变异性较低,这可能为 FSHD 临床试验规划节省样本量。

讨论

EIM 未在 12 个月内发现显著的疾病进展。目前尚不清楚这是由于技术限制,还是由于在此期间,这组 FSHD 患者的疾病进展速度较慢。肌肉神经 58:213-218,2018.

相似文献

1
Electrical impedance myography in facioscapulohumeral muscular dystrophy: A 1-year follow-up study.
Muscle Nerve. 2018 Aug;58(2):213-218. doi: 10.1002/mus.26127. Epub 2018 Apr 17.
2
Electrical impedance myography in facioscapulohumeral muscular dystrophy.
Muscle Nerve. 2016 Oct;54(4):696-701. doi: 10.1002/mus.25065. Epub 2016 May 25.
3
Magnetic resonance imaging correlates with electrical impedance myography in facioscapulohumeral muscular dystrophy.
Muscle Nerve. 2020 May;61(5):644-649. doi: 10.1002/mus.26792. Epub 2020 Jan 22.
6
Electrical impedance myography for assessment of Duchenne muscular dystrophy.
Ann Neurol. 2017 May;81(5):622-632. doi: 10.1002/ana.24874. Epub 2017 May 4.
7
Reducing sample size requirements for future ALS clinical trials with a dedicated electrical impedance myography system.
Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):555-561. doi: 10.1080/21678421.2018.1510008. Epub 2018 Sep 28.
9
Muscle ultrasound is a responsive biomarker in facioscapulohumeral dystrophy.
Neurology. 2020 Apr 7;94(14):e1488-e1494. doi: 10.1212/WNL.0000000000009211. Epub 2020 Mar 4.

引用本文的文献

1
French National Protocol for diagnosis and care of facioscapulohumeral muscular dystrophy (FSHD).
J Neurol. 2024 Sep;271(9):5778-5803. doi: 10.1007/s00415-024-12538-3. Epub 2024 Jul 2.
2
Electrical impedance myography in healthy volunteers.
Muscle Nerve. 2024 Mar;69(3):288-294. doi: 10.1002/mus.27978. Epub 2023 Oct 3.
3
Outcome Measures in Facioscapulohumeral Muscular Dystrophy Clinical Trials.
Cells. 2022 Feb 16;11(4):687. doi: 10.3390/cells11040687.
6
Current Therapeutic Approaches in FSHD.
J Neuromuscul Dis. 2021;8(3):441-451. doi: 10.3233/JND-200554.
7
Therapeutic Approaches in Facioscapulohumeral Muscular Dystrophy.
Trends Mol Med. 2021 Feb;27(2):123-137. doi: 10.1016/j.molmed.2020.09.008. Epub 2020 Oct 19.
8
Fibrogenesis in -Related Muscular Dystrophy Is a Central Tenet of Disease Etiology.
Front Mol Neurosci. 2020 Feb 4;13:3. doi: 10.3389/fnmol.2020.00003. eCollection 2020.
10
Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments.
Neurotherapeutics. 2018 Oct;15(4):863-871. doi: 10.1007/s13311-018-00675-3.

本文引用的文献

1
Adding quantitative muscle MRI to the FSHD clinical trial toolbox.
Neurology. 2017 Nov 14;89(20):2057-2065. doi: 10.1212/WNL.0000000000004647. Epub 2017 Oct 13.
2
Quantitative muscle ultrasound detects disease progression in Duchenne muscular dystrophy.
Ann Neurol. 2017 May;81(5):633-640. doi: 10.1002/ana.24904. Epub 2017 May 4.
4
Electrical impedance myography for assessment of Duchenne muscular dystrophy.
Ann Neurol. 2017 May;81(5):622-632. doi: 10.1002/ana.24874. Epub 2017 May 4.
5
Electrical Impedance Myography and Its Applications in Neuromuscular Disorders.
Neurotherapeutics. 2017 Jan;14(1):107-118. doi: 10.1007/s13311-016-0491-x.
6
The Effect of Subcutaneous Fat on Electrical Impedance Myography: Electrode Configuration and Multi-Frequency Analyses.
PLoS One. 2016 May 26;11(5):e0156154. doi: 10.1371/journal.pone.0156154. eCollection 2016.
7
What's in a name? The clinical features of facioscapulohumeral muscular dystrophy.
Pract Neurol. 2016 Jun;16(3):201-7. doi: 10.1136/practneurol-2015-001353. Epub 2016 Feb 9.
8
Electrical impedance myography in facioscapulohumeral muscular dystrophy.
Muscle Nerve. 2016 Oct;54(4):696-701. doi: 10.1002/mus.25065. Epub 2016 May 25.
10
Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies.
Muscle Nerve. 2015 Oct;52(4):521-6. doi: 10.1002/mus.24621. Epub 2015 Jun 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验